BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Wang Y, Xing Y, Xing R, Liu Y, Xu Y. Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice. Hepatol Res 2020;50:5-14. [PMID: 31661720 DOI: 10.1111/hepr.13444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhong L, Peng X, Wu C, Li Q, Chen Y, Wang M, Li Y, He K, Shi Y, Bie C, Tang S. Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitus. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-022-01080-5] [Reference Citation Analysis]
2 Terada-Ikeda C, Kitabatake M, Hiraku A, Kato K, Yasui S, Imakita N, Ouji-Sageshima N, Iwabuchi N, Hamada K, Ito T. Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol. PLoS One 2020;15:e0238923. [PMID: 32915886 DOI: 10.1371/journal.pone.0238923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Goto M, Iohara D, Michihara A, Ifuku S, Azuma K, Kadowaki D, Maruyama T, Otagiri M, Hirayama F, Anraku M. Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. Int J Biol Macromol 2020;164:659-66. [PMID: 32698063 DOI: 10.1016/j.ijbiomac.2020.07.184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tang R, Li R, Li H, Ma XL, Du P, Yu XY, Ren L, Wang LL, Zheng WS. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 2021. [PMID: 34705426 DOI: 10.1021/acsnano.1c02158] [Reference Citation Analysis]
5 Wang T, Huang S, Wu C, Wang N, Zhang R, Wang M, Mao D. Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine. Evid Based Complement Alternat Med 2021;2021:6682581. [PMID: 33976705 DOI: 10.1155/2021/6682581] [Reference Citation Analysis]
6 Hou L, Wang J, Zhang W, Quan R, Wang D, Zhu S, Jiang H, Wei L, Liu J. Dynamic Alterations of Gut Microbiota in Porcine Circovirus Type 3-Infected Piglets. Front Microbiol 2020;11:1360. [PMID: 32714299 DOI: 10.3389/fmicb.2020.01360] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Dey P, Olmstead BD, Sasaki GY, Vodovotz Y, Yu Z, Bruno RS. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. J Nutr Biochem 2020;84:108455. [PMID: 32688217 DOI: 10.1016/j.jnutbio.2020.108455] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
8 Zhu L, Fu J, Xiao X, Wang F, Jin M, Fang W, Wang Y, Zong X. Faecal microbiota transplantation-mediated jejunal microbiota changes halt high-fat diet-induced obesity in mice via retarding intestinal fat absorption. Microb Biotechnol 2021. [PMID: 34704376 DOI: 10.1111/1751-7915.13951] [Reference Citation Analysis]
9 Křen V, Valentová K. Silybin and its congeners: from traditional medicine to molecular effects. Nat Prod Rep 2022. [PMID: 35510639 DOI: 10.1039/d2np00013j] [Reference Citation Analysis]
10 Luo H, Wu H, Wang L, Xiao S, Lu Y, Liu C, Yu X, Zhang X, Wang Z, Tang L. Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota. Commun Biol 2021;4:1357. [PMID: 34862475 DOI: 10.1038/s42003-021-02883-8] [Reference Citation Analysis]
11 Cui S, Pan XJ, Ge CL, Guo YT, Zhang PF, Yan TT, Zhou JY, He QX, Cheng LH, Wang GJ, Hao HP, Wang H. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α. Chin J Nat Med 2021;19:401-11. [PMID: 34092291 DOI: 10.1016/S1875-5364(21)60039-0] [Reference Citation Analysis]
12 Zhang S, Xu M, Zhang W, Liu C, Chen S. Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications. Int J Mol Sci 2021;22:6110. [PMID: 34204038 DOI: 10.3390/ijms22116110] [Reference Citation Analysis]
13 Yang XF, Lu M, You L, Gen H, Yuan L, Tian T, Li CY, Xu K, Hou J, Lei M. Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology. Chin Med 2021;16:62. [PMID: 34315516 DOI: 10.1186/s13020-021-00470-x] [Reference Citation Analysis]